Abstract
Racemic albuterol has been one of the most widely used β2-adrenoceptor agonists for the relief of the symptoms of asthma, yet the use of β2 agonists has been known to induce bronchial hyperresponsiveness. To probe a possible role of theS-enantiomer for hyperresponsiveness, we determined the effects of (S)-albuterol on intracellular Ca2+ concentration ([Ca2+]i) in dissociated bovine tracheal smooth muscle cells. Both (S)-and (R,S)-albuterol increased [Ca2+]i at concentrations of >10 pm and 1 nm, respectively, with a maximal response by 150 and 100 nm, respectively. (S)-Albuterol (1 and 10 μm) induced Ca2+ oscillations, reaching 1–2 μm[Ca2+]i. This response is in a stark contrast to that of (R)-albuterol, which decreased [Ca2+]i. The increase in [Ca2+]i was blocked by 100 nmatropine or 500 nm4-diphenylacetoxy-N-methylpiperidine but was insensitive to the β2 antagonist ICI 118,551 (10 μm). (S)-Albuterol (10 μm) increased inositol-1,4,5-trisphosphate levels by 213 ± 34.4% (p < 0.05, four experiments) in cells exposed for 30 sec. The sustained phase of the Ca2+ increase was absent in Ca2+-free solution, suggesting that Ca2+ influx was responsible for the sustained Ca2+ response. The results also suggest that (S)-albuterol may cross-react with muscarinic receptors. As a Ca2+ agonist in airway smooth muscle, (S)-albuterol may have profound clinical implications because 50% of prescribed racemic albuterol is composed of (S)-albuterol.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|